FDA approves breakthrough drug for HIV patients with dwindling optionsA new FDA-approved drug offers new hope for patients with multidrug-resistant HIV-1 infection.
First direct-to-consumer test for breast cancer risk hits marketFDA approved the first direct-to-consumer test for three specific BRCA1/BRCA2 breast cancer gene mutations.
FDA warns about fraudulent flu productsDuring the worst flu season in years, FDA is warning consumers about fraudulent and counterfeit flu and antiviral products from online pharmacies.
Pharma makers pull MS drug from worldwide marketIn a rare move, pharmaceutical manufacturers voluntarily recalled their drug to treat multiple sclerosis after reports of serious brain inflammation in patients.
Top 3 new cancer drugsThe first radioactive drug to treat a certain type of cancer is among the top 3 new drug approvals for cancer. Here are the other top cancer drug approvals so far in 2018.
FDA warns about opioid-containing supplementFDA said the manufacturer of dietary supplements containing kratom, a natural opioid used to treat opioid use disorder, agreed to destroy the supplements, and is again warning the public about kratom.
New warning on antibiotic for heart disease patientsFDA is advising caution before healthcare professionals prescribe a certain antibiotic to patients with heart disease due to a potential increased risk of heart problems or death that can occur years later.
3 new FDA drug approvalsFDA recently approved 3 major drugs to treat lung cancer, prostate cancer, and cystic fibrosis. Here are the top 3 new drug approvals.
Patient group pushes FDA to improve biosimilar educationFDA should provide better education about biosimilar drugs on the agency’s web site dedicated to biosimilars, a patient advocacy group said.
Opioid prescription limits gain supportA pharmacist organization is among the supporters of a new Medicare Part D proposal, which calls for a 7-day supply limit on opioid prescriptions.


View Results